-
Considering the Term “Cancer Survivor”
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
Combining Treatment With Hospice Services
Organizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.
by Cheryl Platzman Weinstock
-
Survivor Profile
The Bridge BuilderBreast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
-
Get Involved
That Rings a BellThe End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
-
Forward Look
Breaking Down Breakthrough Cancer TherapiesDrugs approved through this pathway may have limited evidence.
by Lindsey Konkel
-
Policy Matters
Public Funding is the Lifeblood of Cancer ResearchLet your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
-
The Education of a Patient Advocate
Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Reinforcements for Cancer Research
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Does Medicaid Expansion Have an Impact?
Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore